Frequent phosphorylation at serine 392 in overexpressed p53 protein due to missense mutation in carcinoma of the urinary tract

Journal of Pathology

Volumn 197, Issue 1, 2002, Pages 82-88

  Furihata, Mutsuo ^a   Kurabayashl, Atsushi ^a   Matsumoto, Manabu ^b   Sonobe, Hiroshi ^c   Ohtsuki, Yuji ^a   Terao, Naotami ^a   Kuwahara, Morimasa ^b   Shuin, Taro ^c  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Kochi Takasu Hospital   (Japan)

^c Fujisaki Hospital   (Japan)

Author keywords

Direct sequence; Immunohistochemistry; p53; Phosphorylation; Serine 392; Transitional cell carcinoma

Indexed keywords

DNA; PROTEIN P53; SERINE; TETRAMER;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA BINDING; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; OLIGOMERIZATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA; URINARY TRACT SURGERY; WILD TYPE;

AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, TRANSITIONAL CELL; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PHOSPHORYLATION; SERINE; TUMOR SUPPRESSOR PROTEIN P53; UROLOGIC NEOPLASMS;

EID: 0036242150     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1082     Document Type: Article

References (29)

1. p53, the cellular gatekeeper for growth and division
2. Definition of a consensus binding site for p53
3. Crystal structure of a p53 tumour suppressor-DNA complex: Understanding tumourigenic mutations
4. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer
5. TP53 mutations and breast cancer prognosis particularly poor survival rates for cases with mutations in the zinc-binding domains
6. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer
7. The p53 protein is an unusually shaped tetramer that binds directly to DNA
8. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants
9. Sequence-specific transcriptional activation is essential for growth suppression by p53
10. How p53 binds DNA as a tetramer
11. Functional interaction of genes by dominant negative mutations
12. Post-transcriptional modification of p53
13. Signaling to p53: Breaking the MDM2-p53 circuit
14. Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner
15. Small peptide activates the latent sequence-specific DNA binding function of p53
16. Phosphorylation of serine 392 stabilizes the tetramer formation of tumour suppressor protein p53
17. Distinct pattern of p53 phosphorylation in human tumours
18. p53 and human papillomavirus DNA in renal pelvic and ureteral carcinoma including dysplastic lesions
19. Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells
20. Structural aspects of the p53 protein in relation to gene evolution
21. Identification of p53 gene mutations in bladder cancers and urine samples
22. High-risk human papillomavirus infections and over-expression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder
23. The aberrant p53 protein (Review)
24. The polyproline region of p53 is required to activate apoptosis but not growth arrest
25. p53AIPI, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53
26. ARF, and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation
27. Oncogenic mutations of the tumour suppressor: The demons of the guardian of the genome